Unknown

Dataset Information

0

Multi-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma.


ABSTRACT: Rationale: Subsets of patients with early-stage lung adenocarcinoma (LUAD) have a poor post-surgical course after curative surgery. However, biomarkers stratifying this high-risk subset and molecular underpinnings underlying the aggressive phenotype remain unclear. Methods: We integrated bulk and single-cell transcriptomics, proteomics, secretome and spatial profiling of clinical early-stage LUAD samples to identify molecular underpinnings that promote the aggressive phenotype. Results: We identified and validated THBS2, at multi-omic levels, as a tumor size-independent biomarker that robustly predicted post-surgical survival in multiple independent clinical cohorts of early-stage LUAD. Furthermore, scRNA-seq data revealed that THBS2 is exclusively derived from a specific cancer-associated fibroblast (CAF) subset that is distinct from CAFs defined by classical markers. Interestingly, our data demonstrated that THBS2 was preferentially secreted via exosomes in early-stage LUAD tumors with high aggressiveness, and its levels in the peripheral plasma associated with short recurrence-free survival. Further characterization showed that THBS2-high early-stage LUAD was characterized by suppressed antitumor immunity. Specifically, beyond tumor cells, THBS2+ CAFs mainly interact with B and CD8+ T lymphocytes as well as macrophages within tumor microenvironment of early-stage LUAD, and THBS2-high LUAD was associated with decreased immune cell infiltrates but increased immune exhaustion marker. Clinically, high THBS2 expression predicted poor response to immunotherapies and short post-treatment survival of patients. Finally, THBS2 recombinant protein suppressed ex vivo T cells proliferation and promoted in vivo LUAD tumor growth and distant micro-metastasis. Conclusions: Our multi-level analyses uncovered tumor-specific THBS2+ CAFs as a key orchestrator promoting aggressiveness in early-stage LUAD.

SUBMITTER: Yang H 

PROVIDER: S-EPMC9065207 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

Multi-scale integrative analyses identify THBS2<sup>+</sup> cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma.

Yang Haitang H   Sun Beibei B   Fan Liwen L   Ma Wenyan W   Xu Ke K   Hall Sean R R SRR   Wang Zhexin Z   Schmid Ralph A RA   Peng Ren-Wang RW   Marti Thomas M TM   Gao Wen W   Xu Jianlin J   Yang Weiwei W   Yao Feng F  

Theranostics 20220328 7


<b>Rationale:</b> Subsets of patients with early-stage lung adenocarcinoma (LUAD) have a poor post-surgical course after curative surgery. However, biomarkers stratifying this high-risk subset and molecular underpinnings underlying the aggressive phenotype remain unclear. <b>Methods:</b> We integrated bulk and single-cell transcriptomics, proteomics, secretome and spatial profiling of clinical early-stage LUAD samples to identify molecular underpinnings that promote the aggressive phenotype. <b>  ...[more]

Similar Datasets

| S-EPMC10582049 | biostudies-literature
| S-EPMC11833403 | biostudies-literature
| S-EPMC11545076 | biostudies-literature
| S-EPMC11372182 | biostudies-literature
| S-EPMC7956441 | biostudies-literature
| S-EPMC4915822 | biostudies-literature
| S-EPMC5793165 | biostudies-literature
| S-EPMC5796390 | biostudies-literature
| S-EPMC10401097 | biostudies-literature
| S-EPMC11833673 | biostudies-literature